Thyroid Cancer Diagnostics Global Market Report 2025
상품코드:1824466
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
갑상선암 진단 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.1%로 성장할 전망이며, 39억 9,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 동반진단제에 대한 수요 증가, 개인화된 의료에 대한 환자의 선호도 증가, 경제 성장 및 헬스케어 지출, 의사의 교육 및 훈련, 규제 당국의 승인 및 허가에 기인할 것으로 보입니다. 예측 기간 세계 동향에는 리퀴드 바이옵시, 진단 기술의 세계화, 기술의 진보, 연구개발, 인공지능의 통합, 공동연구, 파트너십 등이 있습니다.
향후 5년간의 성장률 6.1%라고 하는 예측은 전회 예측으로부터 0.2%라고 하는 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 무역 마찰은 한국이나 이탈리아에서 개발된 분자 바이오마커 패널 및 라디오파 소작장치의 가격을 높여 암 발견 지연과 내분비 수술 비용 상승을 초래함으로써 미국의 선진적 갑상선 결절 평가 도입을 방해할 수 있습니다. 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더욱 광범위해질 것으로 보입니다.
예상되는 갑상선암 증례 증가는 갑상선암 진단 시장의 확대를 촉진합니다. 갑상선암은 갑상선에 영향을 미치는 질환이며, 치료 성적 향상을 위해서는 조기 발견이 필요합니다. 진단 도구는 갑상선암을 조기에 발견하는 데 중요한 역할을 하며, 효과적인 진단 솔루션에 대한 수요 증가에 대응하고 있습니다. 미국암협회에 의한 2023년 9월 보고서에 따르면 2023년에는 추정 4만 3,720명의 갑상선암 신규 증례가 예상되고 있어 진단 진보의 필요성이 강조되고 있습니다. 이 보고서는 또한 같은 해 갑상선암으로 약 2,120명이 사망할 것으로 예측했습니다. 그 결과, 갑상선암의 유병률 상승은 갑상선암 진단 시장을 추진하는 중요한 요인이 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 갑상선암 진단 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 갑상선암 진단 시장 : 성장률 분석
세계의 갑상선암 진단 시장 실적 : 규모 및 성장(2019-2024년)
세계의 갑상선암 진단 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 갑상선암 진단 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 갑상선암 진단 시장 : 수법 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
화상 검사
혈액 검사
생검
기타 검사 유형
세계의 갑상선암 진단 시장 : 질환 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
유두암
여포암
기타 병
세계의 갑상선암 진단 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 검사실
암 진단센터
연구기관
기타 최종 사용자
세계의 갑상선암 진단 시장 : 화상 검사 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
초음파 영상
컴퓨터 단층 촬영(CT) 스캔
자기 공명 영상법(MRI)
양전자 방출 단층 촬영(PET) 스캔
방사성 요오드 스캔
세계의 갑상선암 진단 시장 : 혈액 검사 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
갑상선 기능 검사
종양 마커 검사
갑상선암 유전자 검사
세계의 갑상선암 진단 시장 : 생검 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세침 흡인 생검(FNA)
코어 바늘 생검
외과적 생검
세계의 갑상선암 진단 시장 : 기타 검사 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
분자 진단
면역조직 화학 검사
조직병리학적 분석
제7장 지역별 및 국가별 분석
세계의 갑상선암 진단 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 갑상선암 진단 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
갑상선암 진단 시장 : 경쟁 구도
갑상선암 진단 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
General Electric : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis International AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sanofi SA
Bristol-Myers Squibb Company
Thermo Fisher Scientific Inc.
Abbott Laboratories
GlaxoSmithKline plc
Eli Lilly and Company
Toshiba Corporation
Merck KGaA
Siemens Healthcare GmbH
FUJIFILM Holdings Corporation
Koninklijke Philips NV
AstraZeneca plc
Agilent Technologies Inc.
Hologic Inc.
Genzyme Corporation
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
갑상선암 진단 시장(2029년) : 새로운 기회를 제공하는 국가
갑상선암 진단 시장(2029년) : 새로운 기회를 제공하는 부문
갑상선암 진단 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Thyroid cancer diagnostics involves the use of techniques to examine a lump or nodule suspected of being thyroid cancer, aiding in the identification and diagnosis of thyroid cancer. Thyroid cancer is a type of cancer that originates in the thyroid gland when cells undergo uncontrolled growth.
The primary techniques used in thyroid cancer diagnostics include imaging tests, blood tests, biopsies, and other diagnostic procedures. Imaging involves creating visual representations of phenomena such as temperature, sound waves, chemicals, or electrical activity. In the context of thyroid cancer diagnostics, imaging tests are utilized to generate images of the thyroid gland. Different types of thyroid cancer include papillary carcinoma, follicular carcinoma, and others. These diagnostic techniques are employed by various end-users, including hospital laboratories, cancer diagnostic centers, research institutes, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The thyroid cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides thyroid cancer diagnostics market statistics, including thyroid cancer diagnostics industry global market size, regional shares, competitors with a thyroid cancer diagnostics market share, detailed thyroid cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid cancer diagnostics industry. This thyroid cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The thyroid cancer diagnostics market size has grown strongly in recent years. It will grow from $2.99 billion in 2024 to $3.15 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increasing prevalence of thyroid cancer, aging population, rising awareness and early detection, government initiatives and funding, improved healthcare infrastructure.
The thyroid cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to growing demand for companion diagnostics, increasing patient preference for personalized medicine, economic growth and healthcare spending, physician education and training, regulatory approvals and clearances. Major trends in the forecast period include liquid biopsies, globalization of diagnostic technologies, technological advancements, research and development, integration of artificial intelligence, collaborations and partnerships.
The forecast of 6.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of advanced thyroid nodule assessment by inflating prices of molecular biomarker panels and radiofrequency ablation devices developed in South Korea and Italy, resulting in delayed cancer detection and higher endocrine surgery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in thyroid cancer cases is set to drive the expansion of the thyroid cancer diagnostic market. Thyroid cancer, a condition affecting the thyroid gland, necessitates early detection for improved treatment outcomes. Diagnostic tools play a crucial role in identifying thyroid cancer at an early stage, meeting the rising demand for effective diagnostic solutions. According to a September 2023 report by the American Cancer Society, an estimated 43,720 new cases of thyroid cancer are expected in 2023, emphasizing the need for diagnostic advancements. The report further projects approximately 2,120 deaths from thyroid cancer in the same year. Consequently, the escalating prevalence of thyroid cancer is a significant driver propelling the thyroid cancer diagnostic market.
The growth of healthcare spending is poised to further boost the thyroid cancer diagnostics market. Healthcare spending, encompassing financial resources allocated to healthcare provision, is a key factor influencing diagnostic market dynamics. The increased investment in healthcare contributes to the research, development, and implementation of advanced diagnostic technologies. This investment enhances accessibility and affordability of innovative tools, fostering early detection and improved management of thyroid cancer. As indicated in the 2021-2030 National Health Expenditure report by the Centers for Medicare & Medicaid Services, the projected annual growth in national health spending is expected to reach 5.1% between 2021 and 2030, totaling nearly $6.8 trillion. With specific focus on Medicare and Medicaid, spending is anticipated to rise at rates of 7.2% and 5.6% annually, respectively. Thus, increased healthcare spending is a key driver fueling the growth of the thyroid cancer diagnostics market.
Major companies in the thyroid cancer diagnostic market are focusing on developing innovative solutions, such as RNA sequencing tests, to improve the accuracy of cancer fusion detection across various solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a high-throughput technique that allows for the analysis of RNA quantity and sequence in a sample, offering insights into gene expression and the overall transcriptome. For example, in March 2024, Foundation Medicine, Inc., a US-based biotechnology company, announced the U.S. launch of FoundationOne RNA, a tissue-based RNA sequencing test designed to detect cancer-related gene fusions across 318 genes. This test provides fusion reporting for all solid tumors and may be especially useful for identifying fusions in cancers such as non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.
Major companies in the thyroid cancer diagnostic market are also focusing on the development of innovative products, such as rearranged during transfection (RET) inhibitors. RET inhibitors specifically target and inhibit the activity of the RET protein. CStone Pharmaceuticals gained approval for GAVRETO (pralsetinib) in March 2022. GAVRETO is a selective RET inhibitor sanctioned in China for managing RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC). This oral targeted therapy addresses the needs of patients with various forms of thyroid cancer, contributing to enhanced diagnostic and treatment options.
In September 2024, The World Tumor Registry (WTR), a US-based non-profit organization focused on the collection and analysis of tumor data, partnered with PathPresenter. This collaboration supports WTR's mission to develop an accessible educational resource for cancer care and research organizations globally, offering a secure and scalable solution to improve cancer diagnostics and education. PathPresenter is a US-based multi-tenant enterprise pathology workflow software platform.
Major companies operating in the thyroid cancer diagnostics market include Pfizer Inc., General Electric, F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Toshiba Corporation, Merck KGaA, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., AstraZeneca plc, Agilent Technologies Inc., Hologic Inc., Genzyme Corporation, Illumina Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc.
North America was the largest region in the thyroid cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the thyroid cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The thyroid cancer diagnostics market includes revenues earned by entities by providing diagnostic tools related detection and diagnosis of thyroid cancer, radioactive tracer, biopsy, blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Thyroid Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on thyroid cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for thyroid cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The thyroid cancer diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Technique Type: Imaging Test; Blood Test; Biopsy; Other Test Type
2) By Disease Type: Papillary Carcinoma; Follicular Carcinoma; Other Diseases
3) By End-User: Hospital Laboratories; Cancer Diagnostic Centers; Research Institutes; Other End-Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Thyroid Cancer Diagnostics Market Characteristics
3. Thyroid Cancer Diagnostics Market Trends And Strategies
4. Thyroid Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Thyroid Cancer Diagnostics Growth Analysis And Strategic Analysis Framework
5.1. Global Thyroid Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Thyroid Cancer Diagnostics Market Growth Rate Analysis
5.4. Global Thyroid Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Thyroid Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Thyroid Cancer Diagnostics Total Addressable Market (TAM)
6. Thyroid Cancer Diagnostics Market Segmentation
6.1. Global Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging Test
Blood Test
Biopsy
Other Test Type
6.2. Global Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Papillary Carcinoma
Follicular Carcinoma
Other Diseases
6.3. Global Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Laboratories
Cancer Diagnostic Centers
Research Institutes
Other End-Users
6.4. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ultrasound Imaging
Computed Tomography (CT) Scans
Magnetic Resonance Imaging (MRI)
Positron Emission Tomography (PET) Scans
Radioactive Iodine Scans
6.5. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Blood Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thyroid Function Tests
Tumor Marker Tests
Genetic Testing For Thyroid Cancer
6.6. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fine Needle Aspiration (FNA) Biopsy
Core Needle Biopsy
Surgical Biopsy
6.7. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Other Test Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Molecular Diagnostics
Immunohistochemistry Tests
Histopathological Analysis
7. Thyroid Cancer Diagnostics Market Regional And Country Analysis
7.1. Global Thyroid Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Thyroid Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Thyroid Cancer Diagnostics Market
8.1. Asia-Pacific Thyroid Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Thyroid Cancer Diagnostics Market
9.1. China Thyroid Cancer Diagnostics Market Overview
9.2. China Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Thyroid Cancer Diagnostics Market
10.1. India Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Thyroid Cancer Diagnostics Market
11.1. Japan Thyroid Cancer Diagnostics Market Overview
11.2. Japan Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Thyroid Cancer Diagnostics Market
12.1. Australia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Thyroid Cancer Diagnostics Market
13.1. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Thyroid Cancer Diagnostics Market
14.1. South Korea Thyroid Cancer Diagnostics Market Overview
14.2. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Thyroid Cancer Diagnostics Market
15.1. Western Europe Thyroid Cancer Diagnostics Market Overview
15.2. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Thyroid Cancer Diagnostics Market
16.1. UK Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Thyroid Cancer Diagnostics Market
17.1. Germany Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Thyroid Cancer Diagnostics Market
18.1. France Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Thyroid Cancer Diagnostics Market
19.1. Italy Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Thyroid Cancer Diagnostics Market
20.1. Spain Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Thyroid Cancer Diagnostics Market
21.1. Eastern Europe Thyroid Cancer Diagnostics Market Overview
21.2. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Thyroid Cancer Diagnostics Market
22.1. Russia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Thyroid Cancer Diagnostics Market
23.1. North America Thyroid Cancer Diagnostics Market Overview
23.2. North America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Thyroid Cancer Diagnostics Market
24.1. USA Thyroid Cancer Diagnostics Market Overview
24.2. USA Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Thyroid Cancer Diagnostics Market
25.1. Canada Thyroid Cancer Diagnostics Market Overview
25.2. Canada Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Thyroid Cancer Diagnostics Market
26.1. South America Thyroid Cancer Diagnostics Market Overview
26.2. South America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Thyroid Cancer Diagnostics Market
27.1. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Thyroid Cancer Diagnostics Market
28.1. Middle East Thyroid Cancer Diagnostics Market Overview
28.2. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Thyroid Cancer Diagnostics Market
29.1. Africa Thyroid Cancer Diagnostics Market Overview
29.2. Africa Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Thyroid Cancer Diagnostics Market Competitive Landscape And Company Profiles
30.1. Thyroid Cancer Diagnostics Market Competitive Landscape
30.2. Thyroid Cancer Diagnostics Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. General Electric Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
31. Thyroid Cancer Diagnostics Market Other Major And Innovative Companies
31.1. Sanofi S.A.
31.2. Bristol-Myers Squibb Company
31.3. Thermo Fisher Scientific Inc.
31.4. Abbott Laboratories
31.5. GlaxoSmithKline plc
31.6. Eli Lilly and Company
31.7. Toshiba Corporation
31.8. Merck KGaA
31.9. Siemens Healthcare GmbH
31.10. FUJIFILM Holdings Corporation
31.11. Koninklijke Philips N.V.
31.12. AstraZeneca plc
31.13. Agilent Technologies Inc.
31.14. Hologic Inc.
31.15. Genzyme Corporation
32. Global Thyroid Cancer Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Thyroid Cancer Diagnostics Market
34. Recent Developments In The Thyroid Cancer Diagnostics Market
35. Thyroid Cancer Diagnostics Market High Potential Countries, Segments and Strategies
35.1 Thyroid Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Thyroid Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Thyroid Cancer Diagnostics Market In 2029 - Growth Strategies
